Parmax Pharma Share Price

BSE
PARMAX •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Parmax Pharma
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
72.62% Gain from 52W Low
-7.2
Dividend yield 1yr %
0

Parmax Pharma shareholding Pattern

Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%

Parmax Pharma Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
8
Bearish Moving Averages
8
5Day EMA
41.60
10Day EMA
41.60
12Day EMA
41.70
20Day EMA
41.80
26Day EMA
41.90
50Day EMA
42.30
100Day EMA
42.20
200Day EMA
40.30
5Day SMA
41.40
10Day SMA
41.50
20Day SMA
41.70
30Day SMA
42.50
50Day SMA
41.90
100Day SMA
44.00
150Day SMA
42.30
200Day SMA
40.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
14 Rs
14 Rs
Week Rs
294 Rs
429 Rs
Month Rs
776 Rs
890 Rs
Resistance & Support
42.16
Pivot
Resistance
First Resistance
42.58
Second Resistance
43.42
Third Resistance
43.84
Support
First Support
41.32
Second support
40.90
Third Support
40.06
Relative Strength Index
49.43
Money Flow Index
76.90
MACD
-0.26
MACD Signal
-0.22
Average True Range
2.81
Average Directional Index
15.77
Rate of Change (21)
-12.60
Rate of Change (125)
7.44

Parmax Pharma Company background

Founded in: 1994
Managing director: Umang Alkesh Gosalia
Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994 the Company had set up a plant to manufacture and market bulk drugs like amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.
Read More

Parmax Pharma FAQs

You can easily buy Parmax Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Parmax Pharma stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -